Selecting the safest and most appropriate device for patients with cancer remains a challenge in health care. While various devices are available, the best way to match a device to a patient’s anatomy, cancer type, and chemotherapy regimen is unclear. To address this gap, the HMS Collaborative has developed the Michigan Appropriateness Guide for Intravenous Catheters – Oncology (MAGIC*Oncology). These guidelines are developed using the RAND/UCLA Appropriateness Method (RAM) that was used to develop the original MAGIC criteria, which are now in use in hundreds of hospitals in the United States and the world. This session will describe the rationale and development of MAGIC Oncology, key findings and recommendations, and how these guidelines can be used to inform practice.

Learning Objectives: At the conclusion of this session, learners will be able to:

• Describe practice patterns (from a statewide multihospital collaborative) related to the use of vascular access devices in patients hospitalized with cancer and/or for cancer-related treatments;

• Describe the risk of vascular access device-related adverse events in patients hospitalized with cancer and/or for cancer-related treatment;

• Identify appropriate use of vascular access devices in patients hospitalized with cancer and/or for cancer-related treatments

Contact Hours: 1
CRNI® RUs: 2